Batavia Biosciences Receives $13.2M Grant to Accelerate Market Access of Low-Cost Inactivated Polio Vaccine

Leiden, The Netherlands, February 25, 2019 – Batavia Biosciences announced today that it received a $13.2 million grant from the Bill & Melinda Gates Foundation to manufacture clinical-grade inactivated polio vaccine (sIPV), using its newly developed low-cost polio vaccine manufacturing… Read More